News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
A double-pronged attack on testicular seminoma
Giving patients a single dose of chemotherapy alongside radiotherapy could improve outcomes for patients with a type of testicular cancer, a new study by The Institute of Cancer Research, London, suggests.
New Alliance to bring lung cancer trials to population of six million
Leading research institutions and hospitals across London today (Thursday, 25 April) unite to transform the care of lung cancer with plans to invite patients over a population of six million into a pioneering new programme of clinical trials.
Scientists track down prostate cancer risk to key ageing gene
Researchers have taken a step further in understanding prostate cancer genetics by fine-mapping an area of a chromosome associated with prostate cancer risk.
Prostate cancer patients with BRCA2 mutations require urgent treatment
Men with the faulty gene who develop prostate cancer need immediate surgery or radiotherapy, as their disease is more aggressive than other types, an ICR study has found.
Identical twins’ genes reveal the ‘silent beginnings’ of leukaemia.
A unique study sequencing the entire genomes of identical twins with leukaemia has identified the first mutations sparking the disease, which could be ideal targets for new cancer drugs.
ICR scientists present at AACR conference
Promising results of clinical trials and the future direction of cancer research are amongst the topics that ICR scientists have been discussing at the American Association for Cancer Research conference this weekend.
Researchers discover drug target for incurable childhood brain cancer
ICR scientists have uncovered the genetic causes of a rare but lethal form of childhood cancer – opening up the prospect of an effective treatment for the disease for the first time.
Coordinating the global hunt for prostate cancer genes
For Professor Ros Eeles, her world-leading work in prostate cancer genetics is about much more than the thrill of scientific discovery. As not only a researcher but a practicing doctor, she is fired by a desire to turn the once theoretical world of cancer genetics into practical advances that have real benefits for patients.
Ground-breaking discovery into the genetic causes of breast cancer
Scientists have discovered 49 new common genetic changes which can lead to the development of breast cancer, more than doubling the number previously known.
Huge study could lead to genetic screening for prostate cancer
Genetic screening for prostate cancer is now a real possibility following results from the largest-ever study into inherited risk factors for the disease. A clinical trial is likely to start this year as a result of the findings.
Luke Johnson is appointed Chairman of the ICR
Leading entrepreneur and former Chairman of Channel 4 will take the helm at the UK’s top academic research centre in August.
Cancer Research Technology and The Institute of Cancer Research enter collaboration with Janssen to discover multiple myeloma drug
A collaboration between the ICR, Cancer Research Technology and Janssen Biotech will seek to discover new multiple myeloma drugs by targeting a key protein on a cell-signalling route called the unfolded protein response (UPR) pathway.
